Logo
Home Herbal Remedies Herbal Products for Pets Aromatherapy Just for Kids
Specials Maladies Search Herbs by Name Articles Tonics

 

 
viw basket
Shipping Policy
Contact Us
Our Mission

 

 

Herbal Remedies for:
Acne, Skin Disorders
ADD/Concentration (12 yrs+)
ADHD (All Ages)
Adrenal Glands
Allergies
Anxiety and Panic Attack
Arthritis, Rheumatism
Asthma
Bad Breath
Bladder Infection, UTI
Bruising
Candida, Yeast Infection
Cholesterol
Circulation
Constipation
Concentration, Study Aid
Depression
Detox Drops
Diabetes
Digestive Disorders
Eczema, Skin Irritation
Energy
Eye Care, Vision
Fertility
Hair Growth, Balding
Hayfever
Headaches, Migraines
Healing
High Blood Pressure
Hyperthyroidism
Hypothyroidism
Immune System Booster
Incontinence
Kidneys
Liver
Memory Problems
Menopause Relief
Menorrhagia
Motion Sicknes
Muscle Pain Relief
Premenstrual Syndrome
Prostate / BPH
Psoriasis
Sexual Performance - Men
Sexual Performance - Women
Sleep Problems
Stop Smoking
Throat and Tonsil
Thyroid
Urinary Tract Infection, UTI
Weight Loss
Just for Kids!
Child Bedwetting
Child Depression
Child Anxiety
Colic
Tantrums
Triple Complex
 Tissue Salts
Asthma Tonic
Brain Tonic
Halitosis Tonic
Incontinence Tonic
Mood Tonic
Nerve Tonic
Nicotine Cravings Tonic
Digestion Tonic
Slimming Tonic
Diabetes Tonic
Sleep Tonic
UTI Tonic
 

 

Ephedra

Botanical Name: Ephedra sinensis/ Ephedra sinica ,  
Common Names:  Ma huang

Overview

Note: Ephedra containing supplements sold over the counter have been banned by the FDA, effective May 2004. See below for additional information.
Ephedra (Ephedra sinica), also called ma huang, has been used in Traditional Chinese Medicine (TCM) for more than 5,000 years. Used in TCM primarily to treat asthma or bronchitis, ephedra is also prescribed for symptoms of cold and flu including nasal congestion, cough, fever, and chills.
While ephedra is a naturally occurring herb, its main active ingredient ephedrine can also be synthesized as a medication. Synthetic ephedrine compounds, such as pseudoephedrine, are widely used in over-the-counter cold remedies and are regulated as a drug. This is unlike the regulation of ephedrine alkaloids derived from the herb itself. These are regulated as a dietary supplements.
Until May 2004, ephedra had been sold commercially as an energy-booster, weight-loss supplement, and athletic performance enhancer. Although some scientific evidence suggests that this herbal supplement may improve weight, the information overall regarding its effectiveness for weight loss, energy, or athletic performance has been inconclusive and controversial. In addition, ephedra-containing products sold for these purposes have been linked to many cases of stroke, heart arrhythmia (irregular heart rhythm), and even death. A number of these products also contain caffeine; the combination of ephedra with caffeine dramatically increases the chances of adverse side effects.
It is important to note that ephedrine containing products are banned from amateur sporting events and evidence of ephedra on drug testing will likely disqualify athletes from competition.
In addition, due to a large body of evidence to support the conclusion, the Food and Drug Administration (FDA) has banned the sale of ephedra-containing dietary supplements, effective May 2004. This ban includes any dietary supplements that contain ephedra, ephedrine, norephedrine, ma huang, Sida cordifolia, or pinellia. This does not pertain to teas (which are regulated as a conventional food) or to traditional Chinese herbal remedies prescribed by traditional Chinese physician.

Plant Description

Ephedra grows on the tundra and on the rocky and sandy slopes of Europe, Asia, and America. The ephedra plant is a perennial evergreen that stands, on average, one foot high but may grow up to four feet. Nearly leafless, the plant has slender, cylindrical, yellow-green branches and underground runners. In August, the flowers bear poisonous, fleshy red cones resembling berries.

Parts Used

The young stems and branchlets are the parts used for medicinal preparations.

Medicinal Uses and Indications

Ephedra is primarily used to treat:

  • Asthma
  • Cough
  • Bronchitis
  • Allergic rhinitis
  • Sinusitis
  • Nasal congestion

Available Forms

Ephedra can be prescribed in dried or liquid form. The American Society of Health-System Pharmacists conducted a study evaluating 20 different ephedra-containing products. The results showed wide variation in the amount of ephedra alkaloids present in the supplements and the actual amount in the products often differed markedly from the amount stated on the label. Follow the advice of a knowledgeable healthcare professional with experience in botanical medicine.

How to Take It

Ephedra should only be used on a short-term basis because prolonged use may lead to addiction. The amount of time considered safe, however, is not clear; sources report anywhere from no longer than seven days to up to twelve consecutive weeks. Use of ephedra should take place ONLY under the guidance and supervision of an appropriately trained specialist. Ephedra should be taken between meals, without food.
Pediatric
The American Botanical Council warns that ephedra SHOULD NOT be used in anyone under the age of 18 without strict medical supervision.
Adult
The German Commission E concluded in 1991 that single adult doses of ephedra should correspond to 15 to 30 mg of total ephedrine alkaloid. Current clinical practices are often more conservative. The doses below specify the standard Commission E recommendations and indicate the more conservative amounts often recommended by specialists when applicable.

  • Infusion or decoction: 1.2 to 2.3 g of cut, dried ephedra herb containing 1.3% (13 mg/g) total alkaloids steeped in 1 cup freshly boiled water three times per day as needed for upper respiratory symptoms
  • Fluid extract 1:1 (g/mL): 1.2 to 2.3 mL (24 to 46 drops) three times per day as needed for upper respiratory symptoms -- this alcohol free liquid form is generally not available in the United States
  • Tincture 1:5 (g/mL): 5.75 to 11.5 mL (115 to 230 drops) three times per day as needed for upper respiratory symptoms; more commonly recommended dose, 1:1.5 g/mL: 0.75 mL to 1.5 mL (15 to 30 drops) three times per day as needed for upper respiratory symptoms
  • Capsules: 12 to 25 mg of total ephedrine alkaloid three times per day as needed for upper respiratory symptoms – used clinically by herbal specialists

Precautions

Herbs contain active substances that can trigger side effects and that can interact with other herbs, supplements, or medications. For these reasons, herbs should be taken with care, under the supervision of a practitioner knowledgeable in the field of botanical medicine.
Ephedra can produce side effects such as irritability, restlessness, anxiety, insomnia, headaches, nausea, vomiting, and urinary problems. More serious side effects include high blood pressure, rapid and/or irregular heart beat, stroke, seizures, addiction, and even death. Use of ephedra should be discontinued and your healthcare professional contacted immediately if you experience any of these adverse effects.
Individuals with certain health conditions including anxiety, depression, high blood pressure, glaucoma, heart disease, prostate enlargement, difficulty urinating, seizure disorder, impaired circulation to the brain, psychiatric disorders, thyroid disorders, or diabetes should not take ephedra. Those taking medications for high blood pressure or depression, and women who are pregnant or breastfeeding, should avoid ephedra and ephedra alkaloids such as ephedrine. To determine whether ephedra is safe and appropriate for you, consult a knowledgeable healthcare provider.

Possible Interactions

While no specific interactions (positive or negative) between the herb ephedra and conventional medications have been reported in the literature, the active ingredients of ephedra, ephedrine and pseudoephedrine (available in a number of over-the-counter and prescription products for weight loss or nasal congestion), have been associated with several serious drug interactions. We may assume, for safety's sake, that those drugs that interact with ephedra's active ingredients may also interact with the herb ephedra. Medications for which there are well-documented interactions with ephedra's active ingredients include:

  • Amphetamine and Amphetamine derivatives (such as dextroamphetamine sometimes used for attention deficit hyperactivity disorder and narcolepsy)
  • Antidepressants; namely, those in the class of tricyclics (such as clomipramine, desipramine, doxepin, imipramine, and nortriptyline) and monoamine oxidase inhibitors (MAOIs, including phenelzine and trancylcypromine)
  • Aspirin 
  • Blood Pressure Medications, particularly clonidine
  • Caffeine and Guarana (a caffeine-containing herb)
  • Narcotics, such as morphine and codeine, prescribed for pain; codeine may also be prescribed for cough
  • Phenylpropanolamine (also known as norephedrine, found in certain supplements); formerly in many over the counter and prescription remedies for cough and cold; was removed from the market by the FDA because of risk of bleeding stroke. Norephedrine found in certain dietary supplements for weight loss can cause liver damage.
  • Theophylline (used for asthma)
 
 

The statements regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. The information on this Web site or in emails is for informational and educational purposes only, and is simply a collection of information in the public domain. Information conveyed herein is based on pharmacological and other records - both ancient and modern. No claims whatsoever can be made as to the specific benefits accruing from the use of any herb or nutrients You should not use this information to diagnose or treat any health problems or illnesses without consulting your pediatrician or family doctor. Please consult a doctor with any questions or concerns you might have regarding your or your child's condition.

All images on this site are property of the original image licensors. The content of these images is not meant to suggest that the person depicted uses or endorses our products or services. Informational material and representations have been provided by the manufacturers of the listed products.

Supporting Research

American Herbal Products Association. http://www.ahpa.org/ on October 25, 2001.
Ang-Lee MK, Moss J, Yuan C-S. Herbal medicines and perioperative care [review]. JAMA. 2001;286(2):208-216.
Bahner DR, Frenia ML, Augenstein WL. Theophylline toxicity from an over-the-counter preparation. J Emerg Med. 1993;11:427-430.
Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA. 2001;286:930-935.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston: Integrative Medicine Communications; 1998:125-126.
Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston: Integrative Medicine Communications; 2000:111-117.
Boada S, Solsona B, Papaceit J, Saludes J, Rull M. Hypotension refractory to ephedrine after sympathetic blockade in a patient on long-term therapy with tricyclic antidepressants [in Spanish]. Rev Esp Anestesiol Reanim. 1999;46(8):364-366.
Boozer CN, Nasser JA, Hemsfield SB, Wang V, Chen G, Solomon JL. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes. 2001;25(3):316-324.
Bucci LR. Selected herbals and human exercise performance. Am J Clin Nutr. 2000;72(2):624S-636S.
Clarkson PM, Thompson HS. Drugs and sport. Research findings and limitations. Sports Med. 1997;24(6):366-384.
Council for Responsible Nutrition. Cantox Health Sciences International Safety Assessment and Determination of a Tolerable Upper Limit for Ephedra. Accessed at http://www.crnusa.org/cantoxreportindex.html on October 25, 2001.
Dambisya YM, Wong CL, Chan K. Ephedrine and phenylpropanolamine potentiate the lethal toxicity of morphine and codeine in naïve mice. Asia Pacific J Pharmacol. 1991;6(3):255-258.
Dawson JK, Earnshaw SM, Graham CS. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. J Accid Emerg Med. 1995;12(1):49-51.
Dingemanse J, Guentert T, Gieschke R, Stabl M. Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A—inhibitor moclobemide. J Cardiovasc Pharmacol. 1996;28:856-861.
Dingemanse J. An update of recent moclobemide interaction data. Int Clin Psychopharmacol. 1993;7(3&4):167-180.
Federal Register. Department of Health and Human Services. Food and Drug Administration. Dietary supplements containing ephedrine alkaloids. April 3, 2000;65(64):17509-17512.
Food and Drug Administration. Consumer Alert: FDA plans regulation prohibiting sale of ephedra-containing dietary supplements and advises consumers to stop using these products. December 30, 2003. Accessed at www.fda.gov/oc/initiatives/ephedra/december 2003/advisory.html on May 5, 2004.